StonvexLoading…
StonvexStonvexStonvexCore line items from CDLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $212.33M | $255.61M | $285.43M | $277.19M |
Operating Income | $-101.82M | $-195.50M | $-135.67M | $-457.78M |
Net Income | $-103.49M | $-189.30M | $-134.70M | $-465.26M |
EPS (Diluted) | $-1.95 | $-3.91 | $-3.69 | $-13.92 |
Total Assets | $285.64M | $392.71M | $574.14M | $691.24M |
Total Liabilities | $292.15M | $322.72M | $439.35M | $479.63M |
Cash & Equivalents | $48.72M | $65.59M | $91.83M | $121.91M |
Free Cash Flow OCF − CapEx | $8.81M | $-10.39M | $-852.00K | $-55.08M |
Shares Outstanding | 54.51M | 51.26M | 39.73M | 33.42M |